About this trial
Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options.
The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.
Eligibility criteria
Qualifiers
Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification.
Persistent pain for at least 3 months, with documented failure of conservative treatment
Age ranging from 60 years of age to 85 years of age
Disqualifiers
Significant shoulder osteoarthritis in the affected shoulder, Hamada classification >2.
Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification.
Comorbidity to the degree that the patient will not be able to participate in the follow up program.
Trial design
Treatments tested in this trial
- Biodegradable spacer
- Debridement and biceps tenotomy